Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes

Diabetologia

Volumn 45, Issue 10, 2002, Pages 1372-1378

  Mittermayer, F ^b   Mayer, B ^b   Meyer, A ^b   Winzer, C ^b   Pacini, G ^c   Wagner, O ^b   Wolzt, M ^a   Kautzky Willer, A ^b  

^a UNIVERSITY OF VIENNA   (Austria)

^b MEDICAL UNIVERSITY OF VIENNA   (Austria)

^c Istituto di Ingeneria Biomedica del CNR   (Italy)

Author keywords

Asymmetrical dimetylarginine; Cholesterol; Gestational diabetes; Insulin resistance; Nitric oxide

Indexed keywords

ARGININE DERIVATIVE; DIMETHYLARGININE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CARDIOVASCULAR DISEASE; CIRCULATION; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HUMAN; INSULIN SENSITIVITY; LIQUID CHROMATOGRAPHY; MULTIPLE REGRESSION; OBESITY; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; RISK FACTOR;

EID: 0036033590     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-002-0916-4     Document Type: Article

References (38)

1. Nathan C (1992) Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051-3064
2. Moncada S, Higgs A (1993) The L-arginine-nitric oxide pathway. N Engl J Med 329: 2002-2012
3. Leiper J, Vallance P (1999) Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovasc Res 43: 542-548
4. Closs EI, Basha FZ, Habermeier A, Forstermann U (1997) Interference of L-arginine analogues with L-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide 1: 65-73
5. Azuma H, Sato J, Hamasaki H, Sugimoto A, Isotani E, Obayashi S (1995) Accumulation of endogenous inhibitors for nitric oxide synthesis and decreased content of L-arginine in regenerated endothelial cells. Br J Pharmacol 115: 1001-1004
6. Bode-Böger SM, Böger RH, Kienke S, Junker W, Frölich JC (1996) Elevated L-arginine/dimethylarginine ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochem Biophys Res Commun 219: 598-603
7. Böger RH, Bode-Böger SM, Szuba A et al. (1998) Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role hypercholesterolemia. Circulation 98: 1842-1847
8. Matsuoka H, Itoh S, Kimoto M et al. (1997) Asymmetrical dimethylarginine, an endogenous nitric oxide synthase inhibitor, in experimental hypertension. Hypertension 29: 242-247
9. Surdacki A, Nowicki M, Sandmann J et al. (1999) Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. J Cardiovasc Pharmacol 33: 652-658
10. Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Frölich JC (1997) Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation 95: 2068-2074
11. Vallance P, Leone A, Calver A, Collier J, Moncada S (1992) Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 339: 572-575
12. Pettersson A, Hedner T, Milsom I (1998) Increased circulating concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in preeclampsia. Acta Obstet Gynecol Scand 77: 808-813
13. Walker HA, McGing E, Fisher I et al. (2001) Endothelium-dependent vasodilation is independent of the plasma L-arginine/ADMA ratio in patients with stable angina: lack of effect of oral L-arginine on endothelial function, oxidative stress and exercise performance. J Am Coll Cardiol 38: 499-505
14. Johnstone MT, Creager SJ, Scales KM, Cusco JA, Lee BK, Creager MA (1993) Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus. Circulation 88: 2510-2516
15. McVeigh GE, Brennan GM, Johnston GD et al. (1992) Impaired endothelium-dependent and independent vasodilation in patients with Type II (non-insulin-dependent) diabetes mellitus. Diabetologia 35: 771-776
16. Anastasiou E, Lekakis JP, Alevizaki M et al. (1998) Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 21: 2111-2115
17. Hu J, Norman M, Wallensteen M, Gennser G (1998) Increased large arterial stiffness and impaired acetylcholine induced skin vasodilatation in women with previous gestational diabetes mellitus. Br J Obstet Gynaecol 105: 1279-1287
18. Fard A, Tuck CH, Donis JA et al. (2000) Acute elevations of plasma asymmetric dimethylarginine and impaired endothelial function in response to a high-fat meal in patients with type 2 diabetes. Arterioscler Thromb Vasc Biol 20: 2039-2044
19. Stühlinger MC, Abbasi F, Chu JW et al. (2002) Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor. JAMA 287: 1420-1426
20. Rolandsson O, Hagg E, Nilsson M, Hallmans G, Mincheva-Nilsson L, Lernmark A (2001) Prediction of diabetes with body mass index, oral glucose tolerance test and islet cell autoantibodies in a regional population. J Intern Med 249: 279-288
21. Ferrannini E, Camastra S (1998) Relationship between impaired glucose tolerance, non-insulin-dependent diabetes mellitus and obesity. Eur J Clin Invest 28 [Suppl 2]: 3-7
22. Kuczmarski RJ, Flegal KM (2000) Criteria for definition of overweight in transition: background and recommendations in the United States. Am J Clin Nutr 72: 1074-1081
23. Pacini G, Tonolo G, Sambataro M et al. (1998) Insulin sensitivity and glucose effectiveness: minimal model analysis of regular and insulin-modified FSIGT. Am J Physiol 274: E592-E599
24. Pettersson A, Uggla L, Backman V (1997) Determination of dimethylated arginines in human plasma by high-performance liquid chromatography. J Chromatogr B Biomed Sci Appl 692: 257-262
25. Valkonen VP, Paiva H, Salonen JT et al. (2001) Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine. Lancet 358: 2127-2128
26. Tamas G, Kerenyi Z (2001) Gestational diabetes: current aspects on pathogenesis and treatment. Exp Clin Endocrinol Diabetes 109 [Suppl 2]: S400-5411
27. Bergman RN, Ader M, Finegood DT, Pacini G (1984) Extrapancreatic effect of somatostatin infusion to increase glucose clearance. Am J Physiol 247: E370-E379
28. Anderstam B, Katzarski K, Bergstrom J (1997) Serum levels of NG, NG-dimethyl-L-arginine, a potential endogenous nitric oxide inhibitor in dialysis patients J Am Soc Nephrol 8: 1437-1442
29. Miyazaki H, Matsuoka H, Cooke JP, Usui M, Ueda S, Okuda S, Imaizumi T (2002) Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis. Circulation 99: 1141-1146
30. Steinberg HO, Chaker H, Leaming R, Johnson A, Brechtel G, Baron AD (1996) Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance. J Clin Invest 97: 2601-2610
31. Ting HH, Timimi FK, Boles KS, Creager SJ, Ganz P, Creager MA (1996) Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 97: 22-28
32. Cuzzocrea S, Riley DP, Caputi AP, Salvemini D (2001) Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury. Pharmacol Rev 53: 135-159
33. Inoguchi T, Li P, Umeda F et al. (2000) High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes 49: 1939-1945
34. Böger RH, Sydow K, Borlak J et al. (2000) LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethio-nine-dependent methyltransferases. Circ Res 87: 99-105
35. Böger RH, Bode-Böger SM, Tsao PS, Lin PS, Chan JR, Cooke JP (2000) An endogenous inhibitor of nitric oxide synthase regulates endothelial adhesiveness for monocytes. J Am Coll Cardiol 36: 2287-2295
36. Lekakis JP, Anastasiou EA, Papamichael CM et al. (2000) Short-term oral ascorbic acid improves endothelium-dependent vasodilatation in women with a history of gestational diabetes mellitus. Diabetes Care 23: 1432-1434
37. Böger RH, Bode-Böger SM (2000) Asymmetric dimethyl-arginine, derangements of the endothelial nitric oxide synthase pathway, and cardiovascular diseases. Semin Thromb Hemost 26: 539-545
38. Böger RH, Bode-Böger SM, Thiele W, Creutzig A, Alexander K, Frölich JC (1998) Restoring vascular nitric oxide formation by L-arginine improves the symptoms of intermittent claudication in patients with peripheral arterial disease. J Am Coll Cardiol 32: 1336-1344